Carboplatin-pemetrexed in treatment of patients with recurrent/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries.

Carboplatin-pemetrexed in treatment of patients with recurrent/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries.

Background – Platinum based therapy in combination with 5-fluorouracil with cetuximab has shown the best survival in pts with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). The purpose of this study is to evaluate the efficacy and tolerability of carboplatin, pemetrex...

Full description

Bibliographic Details
Main Authors: Binu eMalhotra, Emily eBellile, Nghia Pham Trung Nguyen, Vicki Kay Fung, Matthew eSlack, Rebecca eBilich, Silvana ePapagerakis, Francis eWorden
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-01-01
Series:Frontiers in Oncology
Subjects:
Carboplatin
Oropharyngeal Neoplasms
head and neck cancer
Metastatic
recurrent
pemetrexed
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00362/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00362/full

Similar Items